Assisted intelligence for intensive care

At AlgoDx, the premise underlying all our research is the final product’s reliability. Our research methods are based on gold standards used in medical device and pharmaceutical development. We use a scientific, evidence-based approach with regulatory requirements in mind.

NAVOY® product suite

The NAVOY® portfolio includes machine learning algorithms intended to assist clinical decision support in intensive care. Developed for conditions with high unmet medical need, these algorithms are designed to generate robust clinical evidence for product claims, covering clinical and health-economic benefits as well as potential risks.

AlgoDx intensive care proprietary pipeline as of July 2022

Regulatory clearance
Clinical validation
in intensive care
Post-marketing clinical follow-up
NAVOY® Sepsis
NAVOY® Acute Kidney Injury
Undisclosed Therapeutic Indication                                      


Clinical trials – AlgoDx sponsored clinical research

For more information on our ongoing clinical projects in intensive care, visit


Early Prediction of Sepsis in Hospitalized Patients Using a Machine Learning Algorithm, a Randomized Clinical Validation Trial.

Protocol number: NCT04570618


Integration and Evaluation of a Machine Learning Algorithm for Sepsis Prediction in an Electronic Health Record System a Prospective Observational Study.

Protocol number: NCT05095220


Clinical validation of NAVOY® Acute Kidney Injury in ICU patients.

Protocol number: NCT05424874


AlgoDx products in the clinical workflow – case study: NAVOY® Sepsis